When should we consider SGLT-2 inhibitors in patients with acute decompensated heart failure?

Cleve Clin J Med. 2024 Apr 1;91(4):207. doi: 10.3949/ccjm.91c.04001.
No abstract available

Publication types

  • Letter

MeSH terms

  • Diabetes Mellitus, Type 2* / complications
  • Diabetes Mellitus, Type 2* / drug therapy
  • Heart Failure* / drug therapy
  • Humans
  • Hypoglycemic Agents / pharmacology
  • Hypoglycemic Agents / therapeutic use
  • Sodium-Glucose Transporter 2 Inhibitors* / pharmacology
  • Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use

Substances

  • Sodium-Glucose Transporter 2 Inhibitors
  • Hypoglycemic Agents